The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles
Abstract Aims The HFA‐PEFF score was developed to optimize diagnosis and to aid in early recognition of heart failure (HF) with preserved ejection fraction (HFpEF) in patients who present with HF‐like symptoms. Recognizing early‐HFpEF phenogroups is essential to better understand progression towards...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.13861 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540321738653696 |
|---|---|
| author | Michiel T.H.M. Henkens Anne‐Mar vanOmmen Sharon Remmelzwaal Gideon B. Valstar Ping Wang Job A.J. Verdonschot Mark R. Hazebroek Leonard Hofstra Vanessa P.M. vanEmpel Joline W.J. Beulens Hester M. denRuijter Stephane R.B. Heymans |
| author_facet | Michiel T.H.M. Henkens Anne‐Mar vanOmmen Sharon Remmelzwaal Gideon B. Valstar Ping Wang Job A.J. Verdonschot Mark R. Hazebroek Leonard Hofstra Vanessa P.M. vanEmpel Joline W.J. Beulens Hester M. denRuijter Stephane R.B. Heymans |
| author_sort | Michiel T.H.M. Henkens |
| collection | DOAJ |
| description | Abstract Aims The HFA‐PEFF score was developed to optimize diagnosis and to aid in early recognition of heart failure (HF) with preserved ejection fraction (HFpEF) in patients who present with HF‐like symptoms. Recognizing early‐HFpEF phenogroups is essential to better understand progression towards overt HFpEF and pave the way for early intervention and treatment. Whether the HFA‐PEFF domain scores can identify ‘early‐HFpEF’ phenogroups remains unknown. The aims of this pilot study are to (i) identify distinct phenogroups by cluster analysis of HFA‐PEFF domain scores in subjects that present with HF‐like symptoms and (ii) study whether these phenogroups may be associated with distinct blood proteome profiles. Methods and results Subjects referred to the Cardiology Centers of the Netherlands, location Utrecht, with non‐acute possibly cardiac‐related symptoms (such as dyspnoea or fatigue) were prospectively enrolled in the HELPFul cohort (N = 507) and were included in the current analysis. Inclusion criteria for this study were (i) age ≥ 45 years and (ii) a left ventricular ejection fraction (LVEF) ≥ 50%, in the absence of a history of HF, coronary artery disease, congenital heart disease, or any previous cardiac interventions. Multinominal‐based clustering with latent class model using the HFA‐PEFF domain scores (functional, structural, and biomarker scores) as input was used to detect distinct phenotypic clusters. For each bootstrapping run, the 92 Olink proteins were analysed for their association with the identified phenogroups. Four distinct phenogroups were identified in the current analysis (validated by bootstrapping 1000×): (i) no left ventricular diastolic dysfunction (no LVDD, N = 102); (ii) LVDD with functional left ventricular (LV) abnormalities (N = 204); (iii) LVDD with functional and structural LV abnormalities (N = 204); and (iv) LVDD with functional and structural LV abnormalities and elevated BNP (N = 107). The HFA‐PEFF total score risk categories significantly differed between the phenogroups (P < 0.001), with an increase of the HFA‐PEFF score from Phenogroup 1 to 4 (low/intermediate/high HFA‐PEFF risk score: Phenogroup 1: 88%/12%/0%; Phenogroup 2: 9%/91%/0%; Phenogroup 3: 0%/92%/8%; Phenogroup 4: 5%/83%/12%). Thirty‐two out of the 92 Olink protein biomarkers significantly differed among the phenogroups. The top eight biomarkers—N‐terminal prohormone brain natriuretic peptide, growth differentiation factor‐15, matrix metalloproteinase‐2, osteoprotegerin, tissue inhibitor of metalloproteinase‐4, chitinase‐3‐like protein 1, insulin‐like growth factor‐binding protein 2, and insulin‐like growth factor‐binding protein 7—are mainly involved in inflammation and extracellular matrix remodelling, which are currently proposed key processes in HFpEF pathophysiology. Conclusions This study identified distinct phenogroups by using the HFA‐PEFF domain scores in ambulant subjects referred for HF‐like symptoms. The newly identified phenogroups accompanied by their circulating biomarkers profile might aid in a better understanding of the pathophysiological processes involved during the early stages of the HFpEF syndrome. |
| format | Article |
| id | doaj-art-5c2553166de940d19d9f3f472c30a564 |
| institution | Kabale University |
| issn | 2055-5822 |
| language | English |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | ESC Heart Failure |
| spelling | doaj-art-5c2553166de940d19d9f3f472c30a5642025-02-05T05:22:10ZengWileyESC Heart Failure2055-58222022-06-01932032203610.1002/ehf2.13861The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profilesMichiel T.H.M. Henkens0Anne‐Mar vanOmmen1Sharon Remmelzwaal2Gideon B. Valstar3Ping Wang4Job A.J. Verdonschot5Mark R. Hazebroek6Leonard Hofstra7Vanessa P.M. vanEmpel8Joline W.J. Beulens9Hester M. denRuijter10Stephane R.B. Heymans11Department of Cardiology, CARIM Maastricht University Medical Centre Maastricht The NetherlandsLaboratory of Experimental Cardiology, University Medical Center Utrecht Utrecht University Utrecht The NetherlandsDepartment of Epidemiology and Data Science Amsterdam Cardiovascular Sciences Research Institute, Amsterdam UMC, location VUmc Amsterdam The NetherlandsLaboratory of Experimental Cardiology, University Medical Center Utrecht Utrecht University Utrecht The NetherlandsDepartment of Clinical Genetics Maastricht University Medical Centre Maastricht The NetherlandsDepartment of Clinical Genetics Maastricht University Medical Centre Maastricht The NetherlandsDepartment of Cardiology, CARIM Maastricht University Medical Centre Maastricht The NetherlandsCardiology Centers of the Netherlands Utrecht The NetherlandsDepartment of Cardiology, CARIM Maastricht University Medical Centre Maastricht The NetherlandsDepartment of Epidemiology and Data Science Amsterdam Cardiovascular Sciences Research Institute, Amsterdam UMC, location VUmc Amsterdam The NetherlandsLaboratory of Experimental Cardiology, University Medical Center Utrecht Utrecht University Utrecht The NetherlandsDepartment of Cardiology, CARIM Maastricht University Medical Centre Maastricht The NetherlandsAbstract Aims The HFA‐PEFF score was developed to optimize diagnosis and to aid in early recognition of heart failure (HF) with preserved ejection fraction (HFpEF) in patients who present with HF‐like symptoms. Recognizing early‐HFpEF phenogroups is essential to better understand progression towards overt HFpEF and pave the way for early intervention and treatment. Whether the HFA‐PEFF domain scores can identify ‘early‐HFpEF’ phenogroups remains unknown. The aims of this pilot study are to (i) identify distinct phenogroups by cluster analysis of HFA‐PEFF domain scores in subjects that present with HF‐like symptoms and (ii) study whether these phenogroups may be associated with distinct blood proteome profiles. Methods and results Subjects referred to the Cardiology Centers of the Netherlands, location Utrecht, with non‐acute possibly cardiac‐related symptoms (such as dyspnoea or fatigue) were prospectively enrolled in the HELPFul cohort (N = 507) and were included in the current analysis. Inclusion criteria for this study were (i) age ≥ 45 years and (ii) a left ventricular ejection fraction (LVEF) ≥ 50%, in the absence of a history of HF, coronary artery disease, congenital heart disease, or any previous cardiac interventions. Multinominal‐based clustering with latent class model using the HFA‐PEFF domain scores (functional, structural, and biomarker scores) as input was used to detect distinct phenotypic clusters. For each bootstrapping run, the 92 Olink proteins were analysed for their association with the identified phenogroups. Four distinct phenogroups were identified in the current analysis (validated by bootstrapping 1000×): (i) no left ventricular diastolic dysfunction (no LVDD, N = 102); (ii) LVDD with functional left ventricular (LV) abnormalities (N = 204); (iii) LVDD with functional and structural LV abnormalities (N = 204); and (iv) LVDD with functional and structural LV abnormalities and elevated BNP (N = 107). The HFA‐PEFF total score risk categories significantly differed between the phenogroups (P < 0.001), with an increase of the HFA‐PEFF score from Phenogroup 1 to 4 (low/intermediate/high HFA‐PEFF risk score: Phenogroup 1: 88%/12%/0%; Phenogroup 2: 9%/91%/0%; Phenogroup 3: 0%/92%/8%; Phenogroup 4: 5%/83%/12%). Thirty‐two out of the 92 Olink protein biomarkers significantly differed among the phenogroups. The top eight biomarkers—N‐terminal prohormone brain natriuretic peptide, growth differentiation factor‐15, matrix metalloproteinase‐2, osteoprotegerin, tissue inhibitor of metalloproteinase‐4, chitinase‐3‐like protein 1, insulin‐like growth factor‐binding protein 2, and insulin‐like growth factor‐binding protein 7—are mainly involved in inflammation and extracellular matrix remodelling, which are currently proposed key processes in HFpEF pathophysiology. Conclusions This study identified distinct phenogroups by using the HFA‐PEFF domain scores in ambulant subjects referred for HF‐like symptoms. The newly identified phenogroups accompanied by their circulating biomarkers profile might aid in a better understanding of the pathophysiological processes involved during the early stages of the HFpEF syndrome.https://doi.org/10.1002/ehf2.13861HFpEFLeft ventricular diastolic dysfunctionbiomarkersHFA‐PEFF |
| spellingShingle | Michiel T.H.M. Henkens Anne‐Mar vanOmmen Sharon Remmelzwaal Gideon B. Valstar Ping Wang Job A.J. Verdonschot Mark R. Hazebroek Leonard Hofstra Vanessa P.M. vanEmpel Joline W.J. Beulens Hester M. denRuijter Stephane R.B. Heymans The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles ESC Heart Failure HFpEF Left ventricular diastolic dysfunction biomarkers HFA‐PEFF |
| title | The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles |
| title_full | The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles |
| title_fullStr | The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles |
| title_full_unstemmed | The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles |
| title_short | The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles |
| title_sort | hfa peff score identifies early hfpef phenogroups associated with distinct biomarker profiles |
| topic | HFpEF Left ventricular diastolic dysfunction biomarkers HFA‐PEFF |
| url | https://doi.org/10.1002/ehf2.13861 |
| work_keys_str_mv | AT michielthmhenkens thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT annemarvanommen thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT sharonremmelzwaal thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT gideonbvalstar thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT pingwang thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT jobajverdonschot thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT markrhazebroek thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT leonardhofstra thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT vanessapmvanempel thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT jolinewjbeulens thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT hestermdenruijter thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT stephanerbheymans thehfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT michielthmhenkens hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT annemarvanommen hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT sharonremmelzwaal hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT gideonbvalstar hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT pingwang hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT jobajverdonschot hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT markrhazebroek hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT leonardhofstra hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT vanessapmvanempel hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT jolinewjbeulens hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT hestermdenruijter hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles AT stephanerbheymans hfapeffscoreidentifiesearlyhfpefphenogroupsassociatedwithdistinctbiomarkerprofiles |